From Evidence to Enterprise: Unlocking the Innovation Economy for Women's Health

Who will lead the next wave of high-impact innovation in women's health? This session highlights how growing momentum around closing evidence gaps, addressing system-level challenges and redesigning care pathways is opening new opportunities to improve health outcomes and investment in one of the world's most promising innovation markets. Panellists will explore how stronger collaborations can unlock scalable solutions across priority areas in women's health, including cardiovascular conditions, menopause, and cancers- helping translate insight into impact and opportunity. This is the full audio from a session held during the Annual Health Roundtable 2026. Speakers: Moderator: Sonia Muliyil (Editor-in-Chief, The Lancet) Zainab Shinkafi-Bagudu (Board Chair, Founder and Chief Executive Officer, Medicaid Cancer Foundation) Elisabeth Staudinger (Member of the Managing Board, Siemens Healthineers) Julia Hoover (Senior Vice-President, Reproductive Medicine, Ferring Pharmaceuticals), Amy Kao (Senior Vice-President, Global Head of Research Unit in Neuroscience & Immunology, Merck) Check out all our podcasts on wef.ch/podcasts:  YouTube: - https://www.youtube.com/@wef/podcasts Radio Davos - subscribe: https://pod.link/1504682164 Meet the Leader - subscribe: https://pod.link/1534915560 Agenda Dialogues - subscribe: https://pod.link/1574956552